Pulse Biosciences, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulse Biosciences, Inc. on December 14, 2018. The report addresses the closing of a previously announced rights offering.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses solely on the administrative closing of the rights offering.
Material Changes
- Expiration of Rights: The rights offering expired at 5:00 p.m. Eastern Time on December 6, 2018.
- Unexercised Rights: Subscription rights that were not exercised by the expiration date have expired and are no longer exercisable.
- Closing Announcement: The Company publicly announced the closing of the offering via a press release issued on December 14, 2018.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors beyond the standard expiration of unexercised rights. The press release detailing the offering results is attached as Exhibit 99.1 but is not included in the provided text.
Investor Verification Checklist
- Verify the total number of shares issued and the total capital raised in the rights offering by reviewing the attached press release (Exhibit 99.1).
- Confirm the number of subscription rights that remained unexercised and expired.
- Review the Company's subsequent 10-Q or 10-K filings to assess the impact of the capital raise on the balance sheet and cash position.